Cargando…

Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity

Exebacase (CF-301), a novel, antistaphylococcal lysin (cell wall hydrolase) is the first agent of this class to enter late-stage clinical development (phase 3, NCT04160468) for the treatment of Staphylococcus aureus bacteremia, including right-sided endocarditis. A multilaboratory Clinical and Labor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Traczewski, Maria M., Ambler, Jane E., Schuch, Raymond
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Bacteriology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218745/ https://www.ncbi.nlm.nih.gov/pubmed/33910968 http://dx.doi.org/10.1128/JCM.03117-20

Ejemplares similares

The Lysin Exebacase Has a Low Propensity for Resistance Development in Staphylococcus aureus and Suppresses the Emergence of Resistance to Antistaphylococcal Antibiotics
por: Oh, Jun, et al.
Publicado: (2023)

Locally delivered antistaphylococcal lysin exebacase or CF-296 is active in methicillin-resistant Staphylococcus aureus implant-associated osteomyelitis
por: Karau, Melissa, et al.
Publicado: (2022)

Rapid bacteriolysis of Staphylococcus aureus by lysin exebacase
por: Vila-Farres, Xavier, et al.
Publicado: (2023)

Activity of Antistaphylococcal Lysin CF-301 against Contemporary Staphylococcus aureus Clinical Isolates from the USA and Europe
por: Oh, Jun, et al.
Publicado: (2017)

Determination of MIC Quality Control Ranges for Ceftibuten-Avibactam (Fixed 4 μg/mL), a Novel β-Lactam/β-Lactamase Inhibitor Combination
por: Huband, Michael D., et al.
Publicado: (2023)

Sulopenem Disk Development, Quality Control Range, and MIC to Disk Result Correlation for Enterobacterales Isolates
por: Puttagunta, Sailaja, et al.
Publicado: (2023)

Quality Control MIC Ranges Used for Telavancin with Application of a Revised CLSI Reference Broth Microdilution Method
por: Ross, James E., et al.
Publicado: (2014)

Development of a Broth Microdilution Method for Exebacase Susceptibility Testing
por: Oh, Jun T., et al.
Publicado: (2021)

1342. Comparison of Lysin CF-301 (Exebacase) Activity Against S. aureus Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102) to Contemporary Surveillance Isolates
por: Anastasiou, Diane, et al.
Publicado: (2018)

671. Impact of Dose-Administration Strategies of the Antistaphylococcal Lysin Exebacase, (CF-301), in Addition to Daptomycin (DAP) in an Experimental Infective Endocarditis (IE) Model due to Methicillin-Resistant Staphylococcus aureus (MRSA)
por: Xiong, Yan, et al.
Publicado: (2019)

Multicenter Clinical Performance Evaluation of Omadacycline Susceptibility Testing of Enterobacterales on VITEK 2 Systems
por: Csiki-Fejer, Edith, et al.
Publicado: (2023)

Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs
por: Tato, M., et al.
Publicado: (2016)

1550. PK-PD Relationship and PK Driver of Efficacy of the Novel Antibacterial Lysin Exebacase (CF-301) in Pre-Clinical Models
por: Ghahramani, Parviz, et al.
Publicado: (2019)

711. Exebacase (Lysin CF-301) Activity Against Staphylococcus aureus (S. aureus) Isolates From Bacteremic Patients Enrolled in a Phase 2 Study (CF-301-102)
por: Anastasiou, Diane, et al.
Publicado: (2019)

1059. In vitro Activity of Exebacase (CF-301) against Staphylococcus aureus Causing Bacteremia in the United States, Including Multidrug-resistant Subsets
por: Mendes, Rodrigo E, et al.
Publicado: (2021)

Delafloxacin In Vitro Broth Microdilution and Disk Diffusion Antimicrobial Susceptibility Testing Guidelines: Susceptibility Breakpoint Criteria and Quality Control Ranges for an Expanded-Spectrum Anionic Fluoroquinolone
por: Pfaller, M. A., et al.
Publicado: (2018)

Biofilm formation and determination of minimum biofilm eradication concentration of antibiotics in Mycoplasma hyopneumoniae
por: TASSEW, Dereje Damte, et al.
Publicado: (2017)

In vitro activity of exebacase against methicillin-resistant Staphylococcus aureus biofilms on orthopedic Kirschner wires
por: Karau, Melissa J., et al.
Publicado: (2023)

High rate misidentification of biochemically determined Streptococcus isolates from swine clinical specimens
por: MEEKHANON, Nattakan, et al.
Publicado: (2019)

Evaluation of the FilmArray Blood Culture Identification Panel: Results of a Multicenter Controlled Trial
por: Salimnia, Hossein, et al.
Publicado: (2016)

Isolation, identification and characterization of novel Bacillus subtilis
por: LU, Zhenxiang, et al.
Publicado: (2018)

Mismatch Amplification Mutation Assay-Based Real-Time PCR for Rapid Detection of Neisseria gonorrhoeae and Antimicrobial Resistance Determinants in Clinical Specimens
por: Donà, Valentina, et al.
Publicado: (2018)

Development of a novel Trueperella pyogenes-specific PCR assay
por: OCHI, Kenta, et al.
Publicado: (2019)

Identification of a novel Hemoplasma species from pigs in Zhejiang province, China
por: FU, Yuan, et al.
Publicado: (2017)

Detection of Group B Streptococcus Directly from Collected ESwab Samples by Use of the BD Max GBS Assay
por: Silbert, Suzane, et al.
Publicado: (2016)

A Novel Technique for Detecting Antibiotic-Resistant Typhoid from Rapid Diagnostic Tests
por: Nic Fhogartaigh, Caoimhe, et al.
Publicado: (2015)

Genetic analysis of an Erysipelothrix rhusiopathiae swine isolate determined to be serovar 2 by a gel double diffusion test but serovar 1a/2 by a serotyping PCR assay
por: SHIRAIWA, Kazumasa, et al.
Publicado: (2020)

Multicenter Evaluation of the Novel ETEST Fosfomycin for Antimicrobial Susceptibility Testing of Enterobacterales, Enterococcus faecalis, and Staphylococcus Species
por: Goer, A., et al.
Publicado: (2022)

Novel Multilocus Sequence Typing and Global Sequence Clustering Schemes for Characterizing the Population Diversity of Streptococcus mitis
por: Kalizang’oma, Akuzike, et al.
Publicado: (2022)

Membrane vesicle protein PagC as a novel biomarker for detecting pathogenic Salmonella in the viable but not culturable state
por: XU, Jun, et al.
Publicado: (2017)

Clinical Performance of the Novel GenMark Dx ePlex Blood Culture ID Gram-Positive Panel
por: Carroll, Karen C., et al.
Publicado: (2020)

Novel Clinical mNGS-Based Machine Learning Model for Rapid Antimicrobial Susceptibility Testing of Acinetobacter baumannii
por: Hu, Xuejiao, et al.
Publicado: (2023)

Evaluation of a Novel Multiplex High-Definition PCR Assay for Detection of Tick-Borne Pathogens in Whole-Blood Specimens
por: Buchan, Blake W., et al.
Publicado: (2019)

Begerowomyces aurantius sp. nov., a novel yeast isolated from koalas’ habitat in a Japanese zoological park
por: GUO, Yu, et al.
Publicado: (2023)

Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium
por: Fernández-Huerta, Miguel, et al.
Publicado: (2019)

A Novel SimpleProbe PCR Assay for Detection of Mutations in the 23S rRNA Gene Associated with Macrolide Resistance in Mycoplasma genitalium in Clinical Samples
por: Gossé, Marianne, et al.
Publicado: (2016)

Validation and Implementation of a Diagnostic Algorithm for DNA Detection of Bordetella pertussis, B. parapertussis, and B. holmesii in a Pediatric Referral Hospital in Barcelona, Spain
por: Valero-Rello, Ana, et al.
Publicado: (2019)

Development and evaluation of the internal-controlled real-time PCR assay for Rhodococcus equi detection in various clinical specimens
por: STEFAŃSKA, Ilona, et al.
Publicado: (2015)

A novel multiplex PCR assay to detect and distinguish between different types of Paenibacillus larvae and Melissococcus plutonius, and a survey of foulbrood pathogen contamination in Japanese honey
por: OKAMOTO, Mariko, et al.
Publicado: (2022)

Clinical Evaluation of the iCubate iC-GPC Assay for Detection of Gram-Positive Bacteria and Resistance Markers from Positive Blood Cultures
por: Granato, Paul A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_52v72cl959dk6ilks5pqrbn50t